European Heart Journal
Latest articles in this journal
European Heart Journal; doi:10.1093/eurheartj/ehaa007
Abstract:To investigate the associations between major foods and dietary fibre with subtypes of stroke in a large prospective cohort. We analysed data on 418 329 men and women from nine European countries, with an average of 12.7 years of follow-up. Diet was assessed using validated country-specific questionnaires which asked about habitual intake over the past year, calibrated using 24-h recalls. Multivariable-adjusted Cox regressions were used to estimate hazard ratios (HRs) for ischaemic and haemorrhagic stroke associated with consumption of red and processed meat, poultry, fish, dairy foods, eggs, cereals, fruit and vegetables, legumes, nuts and seeds, and dietary fibre. For ischaemic stroke (4281 cases), lower risks were observed with higher consumption of fruit and vegetables combined (HR; 95% CI per 200 g/day higher intake, 0.87; 0.82-0.93, P-trend < 0.001), dietary fibre (per 10 g/day, 0.77; 0.69-0.86, P-trend < 0.001), milk (per 200 g/day, 0.95; 0.91-0.99, P-trend = 0.02), yogurt (per 100 g/day, 0.91; 0.85-0.97, P-trend = 0.004), and cheese (per 30 g/day, 0.88; 0.81-0.97, P-trend = 0.008), while higher risk was observed with higher red meat consumption which attenuated when adjusted for the other statistically significant foods (per 50 g/day, 1.07; 0.96-1.20, P-trend = 0.20). For haemorrhagic stroke (1430 cases), higher risk was associated with higher egg consumption (per 20 g/day, 1.25; 1.09-1.43, P-trend = 0.002). Risk of ischaemic stroke was inversely associated with consumption of fruit and vegetables, dietary fibre, and dairy foods, while risk of haemorrhagic stroke was positively associated with egg consumption. The apparent differences in the associations highlight the importance of examining ischaemic and haemorrhagic stroke subtypes separately.
European Heart Journal; doi:10.1093/eurheartj/ehaa080
European Heart Journal; doi:10.1093/eurheartj/ehaa074
European Heart Journal, Volume 41, pp 899-902; doi:10.1093/eurheartj/ehaa111
Abstract:For the podcast associated with this article, please visit https://academic.oup.com/eurheartj/pages/Podcasts.
European Heart Journal, Volume 41, pp 904-905; doi:10.1093/eurheartj/ehaa063
Abstract:A team of scientists headed by Professor Jos Lelieveld of the Max Planck Institute for Chemistry and Professor Thomas Münzel of the Mainz University Medical Center has recently revealed that air pollution shortens the average life expectancy of Europeans by about 2 years.1 According to the study, around 120 people per 100 000 population die prematurely from the effects of air pollution on a global scale. The corresponding figure for Europe stands at 133 per 100 000 population, which thus exceeds the global average. They also demonstrate that cardiovascular diseases are the cause of death in at least half the incidents (Figure 1).
European Heart Journal, Volume 41, pp 903-903; doi:10.1093/eurheartj/ehaa066
Abstract:There were six cardiology papers listed in the Altmetric’s Score for 2019 of which the article from Thomas Münzel’s group in Mainz, Germany ‘Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions’ in EHJ was in position 72.
European Heart Journal, Volume 41, pp 907-909; doi:10.1093/eurheartj/ehaa064
Abstract:The Heart Centre in the First Affiliated Hospital of Dalian Medical University, Dalian, is in the northeast of China. This is a nationally renowned cardiovascular medical centre, with a history spanning approximately 90 years. There are 11 clinical departments with 350 beds and a research facility with more than 100 cardiologists, research scientists, assistants, and students who are committed to tackling cardiovascular diseases (CVDs). There are six subspecialties in the cardiovascular hospital, which are led by senior scientists, including arrhythmias, coronary heart disease, heart failure, hypertension, cardiovascular surgery, and a cardiac intensive care unit. During the past 10 years in the heart centre, clinical research has been undertaken hand-in-hand with clinical practice and with this approach brings huge benefits to patients.
European Heart Journal; doi:10.1093/eurheartj/ehaa077
The publisher has not yet granted permission to display this abstract.
European Heart Journal, Volume 41, pp 910-910; doi:10.1093/eurheartj/ehaa061
Abstract:Frontiers in CardioVascular Biomedicine (FCVB) is the biennial Congress of the Council on Basic Cardiovascular Science of the ESC thereby representing the majority of cardiovascular science in Europe.
European Heart Journal, Volume 41, pp 906-907; doi:10.1093/eurheartj/ehaa065
Abstract:Several reasons were behind the decision to dedicate a whole meeting on heart failure. Heart failure is a growing epidemic. Its prevalence is increasing worldwide, because of the aging of the population and because of the progress made in medicine allowing patients with myocardial infarction, hypertension, diabetes, end-stage renal disease, and other diseases to live longer and to reach the stage of heart failure.